BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31390093)

  • 1. Predictive factors for successful peripheral blood stem cell mobilization and collection in children.
    Truong TH; Prokopishyn NL; Luu H; Guilcher GMT; Lewis VA
    J Clin Apher; 2019 Oct; 34(5):598-606. PubMed ID: 31390093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days.
    Khouri J; Rybicki L; Majhail N; Kalaycio M; Copelan E; Pohlman B; Hill B; Dean R; Lazaryan A; Hamilton B; Andresen S; Sobecks R; Bolwell B; Liu H
    J Clin Apher; 2018 Jun; 33(3):303-309. PubMed ID: 29134688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
    van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
    J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective collection of peripheral blood stem cells in children weighing 20 kilogram or less in a single large-volume apheresis procedure.
    Salazar-Riojas R; García-Lozano JA; Valdés-Galván M; Martínez-González O; Cantú-Rodríguez OG; González-Llano O; Gómez-De León A; Jaime-Pérez JC; Gómez-Almaguer D; Gutiérrez-Aguirre CH
    J Clin Apher; 2015 Oct; 30(5):281-7. PubMed ID: 25557252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood CD34+ cell enumeration as a predictor of apheresis yield: an analysis of more than 1,000 collections.
    Gambell P; Herbert K; Dickinson M; Stokes K; Bressel M; Wall D; Harrison S; Prince HM
    Biol Blood Marrow Transplant; 2012 May; 18(5):763-72. PubMed ID: 22227589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency.
    Tichelli A; Passweg J; Hoffmann T; Gregor M; Kühne T; Favre G; Wodnar-Filipowicz A; Gratwohl A
    Br J Haematol; 1999 Jul; 106(1):152-8. PubMed ID: 10444178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age on peripheral stem cell mobilization in healthy donors, single center experience.
    Ozen M; Gunduz M; Topcuoglu P; Toprak SK; Dalva K; Gurman G; Ilhan O
    J Clin Apher; 2017 Feb; 32(1):16-20. PubMed ID: 26958783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
    Hsu JW; Shaw BE; Kim S; Logan BR; Sees JA; Confer DL; Pulsipher MA; Shah N; Switzer GE; Abidi MH; Ahmed IA; Anderlini PN; Bredeson C; Chhabra S; Dandoy CE; Diaz MA; Farhadfar N; Ganguly S; Gergis U; Hale GA; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Murthy HS; Olsson RF; Savani BN; Schears R; Seo S; Solh M; Spitzer T; Steinberg A; Sugrue M; Warkentin P; Wingard JR
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1210-1217. PubMed ID: 32088366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.
    Duong HK; Bolwell BJ; Rybicki L; Koo A; Hsi ED; Figueroa P; Dean R; Pohlman B; Kalaycio M; Andresen S; Sobecks R; Copelan E
    J Clin Apher; 2011; 26(3):111-5. PubMed ID: 21647951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing pediatric peripheral blood stem cell collection.
    Sharma N; Sawant RB; Sen S
    Transfus Apher Sci; 2021 Feb; 60(1):102966. PubMed ID: 33268302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide plus granulocyte-colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma.
    Lin TL; Wang PN; Kuo MC; Hung YH; Chang H; Tang TC
    J Clin Apher; 2016 Oct; 31(5):423-8. PubMed ID: 26340986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
    Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
    Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization and collection of peripheral blood stem cells: guidelines for blood volume to process, based on CD34-positive blood cell count in adults and children.
    Anguita-Compagnon AT; Dibarrart MT; Palma J; Paredes L; Mosso C; Montalva R; Salas L; Araos D; Delgado I; Majlis A
    Transplant Proc; 2010; 42(1):339-44. PubMed ID: 20172346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors.
    Fürst D; Hauber D; Reinhardt P; Schauwecker P; Bunjes D; Schulz A; Mytilineos J; Wiesneth M; Schrezenmeier H; Körper S
    Vox Sang; 2019 Apr; 114(3):275-282. PubMed ID: 30873634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
    Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.